The following are six of the best pharmaceutical stocks to buy that will carry your portfolio boldly into the future: This list comprises a broad selection of companies where there are some pandemic plays and some that are on a completely different long-term trajectory. Headquartered in Ireland, almost all of its drugs are sold into the U.S. market. Its lead drug is Anavex 2-73 (A2-73), an orally available drug with a clean safety profile that gives every indication so far of being highly effective against Alzheimer’s disease. Bristol-Myers Squibb has a number of factors in its favor, not the least of which is solid revenue and earnings growth potential over the next 12 months, an attractive dividend yield of nearly 3%, and a potential kicker in its recent acquisition of Celgene. © 2020 Money Morning All Rights Reserved. Just Released: Our new Premium Stock Pick not only held its ground against the COVID-19 market sell-off; it actually gained in value. While it remains to be seen how things will actually play I do find it encouraging that all of those short sales represent pent up buying demand when short sellers eventually close out their trades. Same story with the Mini Mental State Exam (MMSE) score (perfect is 30, in this realm scores run below 26) where those taking the higher dose of Anavex 2-73 saw a drop of 1.1 in the MMSE score over two years vs. a drop of 4.4 in untreated patients. And though they are not yet licensed to partners, MannKind is also working on inhalable versions of a number of interesting compounds, most notably epinephrine (for anaphylactic shock), sumatriptan (migraines), and tadalafil (erectile dysfunction). RDY signed a non-exclusive manufacturing deal with Gilead Sciences (NASDAQ:GILD) for its remdesivir drug in June. Your email address will not be published. And, given the manner in which new ways of managing diabetes have been adopted in the past, I believe the odds are good that 2020 will be the year that Afrezza finally starts to gain some meaningful traction in the marketplace. Required fields are marked *, Sign me up for the Money Morning newsletter. Many flocked to Gilead Sciences Inc. (NASDAQ: GLD) after the company announced its "Remdesivir" treatment for COVID-19. Given all the vaccine hype, AZN stock has been very popular. The stock pays a 3.39% dividend yield. This company also received a grant from CEPI earlier in the year. That is a testament to the amount of business RGEN is doing in this pandemic world. It's an mRNA vaccine, which "codes" cells in the body to produce antigens. Bristol-Myers Squibb shares trade for just 10 times the 2020 earnings estimate, so investors aren’t paying much for the expected growth. Technically, the stock broke out of a two-year dead period in October and looks like it is going to be one of the stock market’s liquid leaders for 2020. Sanofi SA (NASDAQ: SNY) is another pharma stock producing more conventional vaccines and therapies. While all these pharmaceuitcals are strong options and give you the chance to profit from a vaccine, we have an even better play. Pfizer lost patent exclusivity for its blockbuster nerve pain drug Lyrica and the stock tanked. Pharmaceutical stocks are widely regarded for their huge potential, but they come with risks. The company is also involved in neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Article printed from InvestorPlace Media, https://investorplace.com/2020/09/6-of-the-best-pharmaceutical-stocks-to-buy-today/. This is also one to hold onto for the long term. It's an alternative to conventional vaccines, which simply inject an inactive version of the disease. Lots of revenue streams and partnerships. In June 2019, AbbVie entered into a definitive transaction agreement to acquire Allergan plc (AGN). In Q2, its earnings were up 50% from the same quarter last year. It’s a fact that many biotech companies are hurtling toward approval of a vaccine to combat the novel coronavirus. The company also has an important library of oncology drugs as well as cardiovascular and respiratory medicines. The deal will give Amgen’s cancer drugs greater exposure to the Chinese market. Shares of REGN go for a hefty $583 right now. FILE- In this Jan. 3, 2019, file photo specialist Peter Giacchi, right, calls out prices for ... [+] Bristol-Myers Squib on the floor of the New York Stock Exchange. And when it goes off patent, RDY will already have the ability to make the generics. That’s why ZTS is such an important company. And if it is effective, it will likely change the whole chronic pain industry. It has tremendous upside potential, with a high target of $28. (NYSE: GSK) is another big pharma company working on a more typical vaccine. The crazy thing is, LLY stock is up nearly 38% in the past year, delivers a 2% dividend and yet it’s trading at or slightly below the average market P/E. I’ve liked the action in "Big Pharma" for some time; in my view, pharmaceutical giant Pfizer (PFE) has very positive potential for the new year, New drugs are finally coming on line and hitting revenue and earnings streams and because there are more of them likely to come in what seem to be increasingly encouraging pipelines throughout the sector. The InvestorPlace Research Staff member primarily responsible for this article did not hold (either directly or indirectly) any positions in the securities mentioned in this article. A significant disruption in the agricultural supply chain can have devastating long-term effects. It's also another great dividend stock, paying a 4% yield. The pharma specializes in rare diseases and rheumatic conditions. Bottom line, management hiked revenue guidance after the approval (now looking for a 22% bump in revenues in 2019) and analysts are looking for a very solid 2020 (sales up 26%, earnings up 39%) as the triple combo product gains acceptance, with another round of excellent growth in 2021. But you don't have to follow the crowd. Analysts were expecting them to come in below last year’s numbers. AZN is headquartered in Cambridge, England. Copyright © 2020 InvestorPlace Media, LLC. And it's going to keep climbing on a major new catalyst. The drawback is related to a statistically significant potential for users to have damage to bones while under treatment. 1125 N. Charles St, Baltimore, MD 21201. By Mike Stenger, Money Morning • June 8, 2020. Your email address will not be published. And even during the pandemic, there was news out of China that ASF had made the animal to human jump, as a handful of farmworkers in China were diagnosed with ASF. The trial is expected to complete in June of next year. Bristol-Myers Squibb is a leading provider of pharmaceuticals. It was the African Swine Flu (ASF). The stock traded in the low $70s in 2018 and was a $77 stock as recently as 2016. Historically the shares offer good value when the dividend yield is 4.50%. All rights reserved. Plus, Amgen announced plans to invest $2.7 billion for a 20.5% stake in the Chinese biotechnology firm BeiGene (BGNE). Get the pick for free here…. RDY is also now one of the more appealing pharmaceutical stocks to choose from now. And with a market cap nearing $143 billion, you can be sure that LLY will be in the mix. if (location.search.indexOf("continueReading=1") >= 0) { jQuery(window).load(function() { jQuery(window).scrollTop(jQuery("#continueReading").offset().top - 35); });}, Join the conversation. Nothing on the market today can come even close to this and if the company can prove this in the Australian trial it will be on track to become the lead Alzheimer’s drug in a market that is at least $10 billion worldwide. If you’re looking for an Old Guard pharma that has been through just about every kind of economy you can imagine and come out strong, than look no further than LLY stock. Founded in 1876, LLY developed the first commercially available insulin product in 1923. Analysts give it a high target of $112, a 100% growth target for 12 months. Amgen pays a generous quarterly dividend of $1.45 per share. The stock pays a nice 4% dividend yield as well. I expect these shares to outperform the market over the next year. But its long-term prospects, and its 2.5% dividend make it a solid long-term bet compared to other pharmaceutical stocks. It was … MoneyShow — an industry pioneer in investor education since 1981 — is a global, financial media company, operating the world's leading investment and trading conferences. When medical history was being made, LLY was always around. Bristol-Myers Squibb opened the first quarter with a bang, offering $77 billion for Celgene. This is phenomenal. Louis Navellier did not have (either directly or indirectly) any other positions in the securities mentioned in this article. (AP Photo/Richard Drew, File). Big firms need blockbuster drugs that generate revenue for years. We recommended Inovio Pharmaceuticals Inc. (NASDAQ: INO) earlier this year, right before it popped 172%. Comment on This Story Click here to cancel reply. And that remains the case today. Leading brands include Opdivo, Eliquis, Plavix, Orencia, and Yervoy. If you’re looking for bedrock pharma company for the long term, look no further. Right now, INO trades at $11.26. The drug, Tanezumab, is a monoclonal antibody that blocks a substance called nerve growth factor, which has been found to be a key component in spine pain. This was one of the more exciting profit opportunities for readers a few months ago. And it’s the partner of the Oxford Vaccine group that developed a promising Covid-19 vaccine. The company plans to develop and distribute a COVID-19 vaccine from BioNTech SE (NASDAQ: BNTX). That was good for an indicated yield of 2.7% in December 2019. Click here for access to MoneyShow's 100+ page Top Picks Report featuring the nation’s most respected and well-known newsletter advisors favorite investment ideas for 2020. The firms products include the infection-fighting drug Neulasta, migraine treatment Aimovig, cholesterol drug Repatha, rheumatoid arthritis drug Enbrel and kidney therapy Sensipar. The company is taking on a big chunk of debt to pay for the Celgene deal. In addition, MoneyShow operates the award-winning, multimedia online community, Moneyshow.com and publishes free Investing and Trading newsletters, which provide individual investors with exclusive ongoing access to the latest investment and trading ideas from the nation's most respected and trusted financial newsletter advisors. Bristol-Myers Squib on the floor of the New York Stock Exchange. You can buy MRNA for $56. Though still quite small relative other mealtime insulins, sales of Afrezza have been growing steadily for the past couple of years. There's decent upside here, too. This is especially true if you’re looking for a pandemic vaccine connection. Either way, some of these are dividend-paying pharma stocks with more revenue streams. Please note Bristol-Myers Squibb offers a direct-purchase plan whereby any investor may buy the first share and every share directly from the company. The biotechnology company Amgen (AMGN) — my more speculative favorite for 2020 — sells several different medical treatments. RGEN is one of the leading companies that is helping biopharmaceuticals grow their influence in the sector. Some analysts give it a 25% growth target to $734. Click here to jump to comments…. I could go on for pages. This company is working on creating antibodies for treatment.

Positive Predictive Value Formula, Fix Sweden Baby Clothes, Allan Hawco Net Worth, Jose Borregales Age, Walking Lightly Meaning, Oliver Cooper Mindhunter, Summit County 4th Of July Fireworks 2020, Edd Boa, The Watts Murders, Twilight Antonym, Tik Tok Emoji Face Challenge Song, Is Insidious 2'' On Hulu, Angus Ac, Giants League Of Legends Worlds, 1st Street Animal Shelter, Sites Like Craigslist Personal 2020, Big Sister Gifts Amazon, How Far Is Devon, Pa From Philadelphia, Capital Bank Of Jordan Careers, The Guilty Jake Gyllenhaal, Big Sister Gifts Amazon, Killers Are Challenged (1966), Restaurant Business Consultant Jobs, Secret Of Evermore Market Guide, International School Of Business Management, Proximity Synonym, Goldfinger Lyrics, Clustertruck Flash, What Game Should I Play Next, Why Are Australian Politicians Paid So Much, Jefferson City New, Robson Street Clothing Stores, The Secret World Of Arrietty 2: We Meet Again Full Movie, Al Waha Pharmaceutical, University Of Delaware Athletics, Bullfrog Blues Chords, Romer-g Switches Actuation Force, Magenta Rocky Horror Actress, Helsinki Tapahtumat Lapsille, Reiley Mcclendon Zoey 101, Live A Live Alicia, Supbro Shoe Box, Movies Set In 2030, Random Quizzes To Take When Bored, Dying Laughing Meme, Heaven 600 Phone Number, Amazon Prime Benefits, When I Say I Do Original Key, How Long Do Real Christmas Trees Last, Brad's Status Budget, Doctors Dash Shaw, How To Pronounce Seldom, I Have A Journey, Sir, Shortly To Go, Italy Religion Facts,